Trend of ciprofloxacin resistance in Neisseria gonorrhoeae strains isolated in Italy and analysis of the molecular determinants

Diagnostic Microbiology and Infectious Disease

Volumn 67, Issue 4, 2010, Pages 350-354

  Starnino, Stefania ^a   Dal Conte, Ivano ^b   Matteelli, Alberto ^c   Galluppi, Emma ^d   Cusini, Marco ^e   Di Carlo, Aldo ^f   Delmonte, Sergio ^g   Stefanelli, Paola ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b STI Clinic Savoia Hospital   (Italy)

^c UNIVERSITY OF BRESCIA   (Italy)

^d UNIVERSITY OF BOLOGNA   (Italy)

^e Fondazione Policlinico Mangiagalli Regina Elena   (Italy)

^f SAN GALLICANO DERMATOLOGICAL INSTITUTE   (Italy)

^g SC Dermosifilopatia 2 ASO US Giovanni Battista   (Italy)

Author keywords

Ciprofloxacin resistance; Molecular analysis; Neisseria gonorrhoeae

Indexed keywords

CIPROFLOXACIN; DNA TOPOISOMERASE (ATP HYDROLYSING) A; PROTEIN PARC; ANTIINFECTIVE AGENT; BACTERIAL DNA; DNA TOPOISOMERASE (ATP HYDROLYSING); DNA TOPOISOMERASE IV;

ADOLESCENT; ADULT; AGED; AMINO ACID SEQUENCE; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CONTROLLED STUDY; FEMALE; GENE AMPLIFICATION; GENE MUTATION; GENE SEQUENCE; GONORRHEA; HUMAN; ITALY; MAJOR CLINICAL STUDY; MALE; MALE HOMOSEXUAL; MINIMUM INHIBITORY CONCENTRATION; NEISSERIA GONORRHOEAE; NONHUMAN; PRIORITY JOURNAL; SEROTYPE; TREND STUDY; BACTERIAL GENE; DNA SEQUENCE; DRUG EFFECTS; GENETICS; ISOLATION AND PURIFICATION; MALE HOMOSEXUALITY; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MIDDLE AGED; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ANTI-BACTERIAL AGENTS; CIPROFLOXACIN; DNA GYRASE; DNA TOPOISOMERASE IV; DNA, BACTERIAL; DRUG RESISTANCE, BACTERIAL; FEMALE; GENES, BACTERIAL; GONORRHEA; HOMOSEXUALITY, MALE; HUMANS; ITALY; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; NEISSERIA GONORRHOEAE; SEQUENCE ANALYSIS, DNA; YOUNG ADULT;

EID: 77954750346     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2010.03.001     Document Type: Article

References (29)

1. Arreaza L., Salcedo C., Alcalà B., Berrón S., Martín E., Vázquez J.A. Antibiotic resistance of Neisseria gonorrhoeae in Spain: trends over the last two decades. J. Antimicrob. Chemother. 2003, 51:153-156.
2. Bauer H.M., Mark K.E., Samuel M., Wang S.A., Weismuller P., Moore D., Gunn R.A., Peter C., Vannier A., Deaugustine N., Klausner J.D., Knapp J.S., Bolan G. Prevalence of and associated risk factors for fluoroquinolone-resistant Neisseria gonorrhoeae in California. Clin. Infect. Dis. 2005, 41:795-803.
3. Belland R.J., Morrison S.G., Ison C., Huang W.M. Neisseria gonorrhoeae acquires mutations in analogous region of gyrA and parC in fluoroquinolones-resistant isolates. Mol. Microbiol. 1994, 14:371-380.
4. Bignell C., IUSTI/WHO European (IUSTI/WHO) guideline on the diagnosis and treatment of gonorrhoea in adults. Int. J. STD & AIDS 2009, 20:453-457.
5. Centre for Disease Control and Prevention (CDC) Increases in fluoroquinolones-resistant Neisseria gonorrhoeae among men who have sex with men United States, 2003, and revised recommendations for gonorrhoea treatment. MMWR 2004, 53:335-338.
6. Centre for Disease Control and Prevention (CDC) Update to CDC's sexually transmitted disease treatment guidelines, 2006: fluoroquinolones no longer recommended for treatment of gonococcal infection. MMWR 2007, 56:332-336.
7. Chaundry U., Ray K., Bala M., Saluja D. Mutation patterns in gyrA and parC genes of ciprofloxacin resistant isolates of Neisseria gonorrhoeae from India. Sex. Transm. Infect. 2002, 78:440-444.
8. Clinical and Laboratory Standard Institute (CLSI) Performance standards for antimicrobial susceptibility testing: 18th informational supplement (M100-S18) 2008, CLSI, Wayne, PA.
9. De Jongh M., Dangor Y., Adam A., Hoosen A.A. Gonococcal resistance: evolving from penicillin, tetracycline to the quinolones in South Africa-implications for treatment guidelines. Int. J. STD AIDS 2007, 18:697-699.
10. Dewi B.E., Akira S., Hayashi H., Ba-Thein W. High occurrence of simultaneous mutations in target enzymes and MtrRCDE efflux system in quinolone-resistant Neisseria gonorrhoeae. Sex. Transm. Dis. 2004, 31:353-359.
11. Euro-GASP, European gonococcal antimicrobial surveillance programme annual report no 3, 2008. Available at: Accessed January 8, 2010. http://www.ecdc.europa.eu/en/activities/surveillance/ESSTI/Pages/ESSTI%20Project.aspx.
12. Fenton K.A., Ison C., Johnson AP Rudd E., Soltani M., Martin I., Nichols T., Livermore D.M. Ciprofloxacin resistance in Neisseria gonorrhoeae in England and in Wales in 2002. Lancet 2003, 361:1867-1869. GRASP collaboration.
13. Le Lin B., Pastore R., Liassine N., Aramburu C., Sudre P. A new sexually transmitted infection (STI) in Geneva? Ciprofloxacin-resistant Neisseria gonorrhoeae, 2002-2005. Swiss Med. Wkly. 2008, 138:243-246.
14. Lewis D.A., Scott L., Slabbert M., Mhlongo S., van Zijl A., Sello M., du Plessis N., Radebe F., Wasserman E. Escalation in the relative prevalence of ciprofloxacin-resistant gonorrhea among men with urethral discharge in two South African cities: association HIV seropositivity. Sex. Transm. Infect. 2008, 84:352-355.
15. Lindbäck E., Rahman M., Jalal S., Wretlind B. Mutations in gyrA, gyrB, parC, and parE in quinolone-resistant strains of Neisseria gonorrhoeae. APMIS 2002, 110:651-657.
16. Martin I.M., Ison C.A., Aanensen D.M., Fenton K.A., Spratt B.G. Rapid sequence-based identification of gonococcal transmission clusters in a large metropolitan area. J. Infect. Dis. 2004, 189:497-505.
17. Martin I.M., Hoffmann S., Ison C.A., Network ESSTI European Surveillance of Sexually Transmitted Infections (ESSTI): the first combined antimicrobial susceptibility data for Neisseria gonorrhoeae in Western Europe. J. Antimicrob. Chemother. 2006, 58:587-593.
18. Mavroidi A., Tzouvelekis L.S., Kyriakis K.P., Avgerinou H., Daniilidou M., Tzelepi E. Multidrug-resistant strains of Neisseria gonorrhoeae in Greece. Antimicrob. Agents Chemother. 2001, 45:2651-2654.
19. Moran J.S., Zenilman J.M. Therapy for gonococcal infections: options in 1989. Rev. Infect. Dis. 1990, 12:633-644.
20. Starnino S., Stefanelli P. Azithromycin-resistant Neisseria gonorrhoeae strains recently isolated in Italy. J. Antimicrob. Chemother. 2009, 63:1200-1204. on behalf of the Neisseria gonorrhoeae Italian Study Group.
21. Starnino S., Suligoi B., Regine V., Bilek N., Stefanelli P. Phenotypic and genotypic characterization of Neisseria gonorrhoeae in parts of Italy: detection of a multiresistant cluster circulating in a heterosexual network. Clin. Microbiol. Infect. 2008, 14:949-954. Neisseria gonorrhoeae Italian Study Group.
22. Su X., Lind I. Molecular basis of high level ciprofloxacin resistance in Neisseria gonorrhoeae strains isolated in Denmark from 1995 to 1998. Antimicrob. Agents Chemother. 2001, 45:117-123.
23. Tanaka M., Nakayama H., Haraoka M., Saika T. Antimicrobial resistance of Neisseria gonorrhoeae and high prevalence of ciprofloxacin-resistant isolates in Japan, 1993 to 1998. J. Clin. Microbiol. 2000, 38:521-525.
24. Tapsall J. Multidrug-resistant Neisseria gonorrhoeae. CMAJ 2009, 180:268-269.
25. Tompkins J.R., Zenilman J.M. Quinolone resistance in Neisseria gonorrhoeae. Curr. Infect. Dis. Rep. 2001, 3:156-161.
26. Vereshchagin V.A., Ilina E.N., Malakhova M.V., Zubkov M.M., Sidorenko S.V., Kubanova A.A., Govorun V.M. Fluoroquinolone-resistant Neisseria gonorrhoeae isolates from Russia: molecular mechanism implicated. J. Antimicrob. Chemother. 2004, 53:653-656.
27. Vernel-Pauillac F., Hogan T.R., Tapsall J.W., Goarant C. Quinolone resistance in Neisseria gonorrhoeae: rapid genotyping of quinolone resistance-determining regions in gyrA and parC genes by melting curve analysis predicts susceptibility. Antimicrob. Agents Chemother. 2009, 53:1264-1267.
28. Wang S.A., Harvey A.B., Conner S.M., Zaidi A.A., Knapp J.S., Whittington W.L., del Rio C., Judson F.N., Holmes K.K. Antimicrobial resistance in Neisseria gonorrhoeae in United States, 1988 to 2003: the spread of fluoroquinolone resistance. Ann. Intern. Med. 2007, 147:81-88.
29. Wong W.W., Huang C.T., Li L.H., Chiang C.C., Chen B.D., Li S.Y. Molecular epidemiological identification of Neisseria gonorrhoeae clonal clusters with distinct susceptibility profiles associated with specific groups at high risk of contracting human immunodeficiency virus and syphilis. J. Clin. Microbiol. 2008, 46:3931-3934.